LICENSE AGREEMENT by and between KARYOPHARM THERAPEUTICS INC. and ONO PHARMACEUTICAL CO., LTD.License Agreement • March 15th, 2018 • Karyopharm Therapeutics Inc. • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (this “Agreement”), effective as of October 11, 2017 (the “Effective Date”), is made and entered into by and between Karyopharm Therapeutics Inc., a corporation organized and existing under the laws of the State of Delaware, having an address at 85 Wells Avenue, Suite 210, Newton, MA 02459 USA (“Karyopharm”), and Ono Pharmaceutical Co., Ltd., a corporation organized and existing under the laws of Japan, having an address at 8-2, Kyutaro-machi 1-chome, Chuo-ku, Osaka, Osaka 541-8564, Japan (“Ono”). Karyopharm and Ono are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
